BA
SBRA icon

Bristlecone Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bristlecone Advisors’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,274
Closed -$219K – 197
2019
Q4 		$219K Buy
+10,274
New +$230K 0.04% 189

Other funds holding SBRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPC
Long Pond Capital New York $1.05B AUM 16.49% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bristlecone Advisors's SBRA Position: Q1 2020 in Review

Bristlecone Advisors sold out of Sabra Healthcare REIT (SBRA) in Q1 2020, closing a stake of 10,274 shares — an estimated $219K sold.

Bristlecone Advisors first reported a position in SBRA in Q4 2019 and held it in 1 quarter. The position peaked at $219K in Q4 2019. 324 funds tracked by Wall St. Rank hold SBRA as of Q1 2020.

  • Bristlecone Advisors reported no remaining Sabra Healthcare REIT position as of Q1 2020 after selling out during the quarter.
  • Bristlecone Advisors sold 10,274 Sabra Healthcare REIT shares in Q1 2020, an estimated $219K.
  • Bristlecone Advisors first reported a position in Sabra Healthcare REIT in Q4 2019 and held it in 1 quarter.
  • Bristlecone Advisors's Sabra Healthcare REIT position peaked at $219K in Q4 2019.
  • 324 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2020.

Based on Bristlecone Advisors's 13F filing for Q1 2020, filed 16 Apr 2020.